Furthermore, 10 μM EGCG had enhanced cisplatin sensitivity in ovarian cancer cell lines by regulating the expression of copper and cisplatin influx transport which is well-known as copper transporter 1 (CTR1) [123]. The gene discussed is SLC31A1; the disease is ovarian cancer.